TGFB1 and breast carcinoma: Among breast cancers, TGF-β over-expression has been implicated in the EMT by mediating the functional conversion of TGF-β during breast cancer progression, suggesting that the chemotherapeutic targeting of EMT induced by TGF-β may offer new inroads in treating metastatic disease in breast cancer patients [3,13].